Nexus AG
XETRA:NXU

Watchlist Manager
Nexus AG Logo
Nexus AG
XETRA:NXU
Watchlist
Price: 69.5 EUR -0.57% Market Closed
Market Cap: 1.2B EUR
Have any thoughts about
Nexus AG?
Write Note

Nexus AG
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nexus AG
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Nexus AG
XETRA:NXU
Net Change in Cash
€5.7m
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
23%
CompuGroup Medical SE & Co KgaA
XETRA:COP
Net Change in Cash
€19.7m
CAGR 3-Years
N/A
CAGR 5-Years
18%
CAGR 10-Years
N/A
DocCheck AG
XETRA:AJ91
Net Change in Cash
€976.1k
CAGR 3-Years
-53%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
CHAPTERS Group AG
XETRA:CHG
Net Change in Cash
€24.6m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Nexus AG
Glance View

Market Cap
1.2B EUR
Industry
Health Care

Nexus AG, a prominent figure in the healthcare IT sector, has carved a niche for itself by specializing in software solutions that enhance the operational efficiency and care quality of hospitals and healthcare institutions. Founded with a vision to bridge the gap between innovative technology and healthcare services, Nexus AG crafts integrated software platforms that streamline hospital workflows, from patient admission to billing processes. This not only helps healthcare providers improve service delivery but also allows for smoother regulatory compliance and administrative management. By understanding the unique challenges faced by healthcare professionals, Nexus AG has positioned itself as an indispensable partner to over a thousand hospitals across Europe and beyond. The revenue model of Nexus AG hinges on the strategic deployment of its software solutions, combining upfront licensing fees with ongoing maintenance and support contracts. This ensures a steady stream of recurring revenue, bolstered by consultancy services and tailored modifications that meet client-specific needs. The company continuously invests in research and development to keep its offerings cutting-edge, while also exploring expansion opportunities in adjacent markets and technologies. By fostering long-term relationships with its clients, Nexus AG transforms technological advancement into tangible solutions that provide efficiency and cost savings for the healthcare sector, sustaining its growth and relevance in an ever-evolving market.

NXU Intrinsic Value
60.23 EUR
Overvaluation 13%
Intrinsic Value
Price

See Also

What is Nexus AG's Net Change in Cash?
Net Change in Cash
5.7m EUR

Based on the financial report for Sep 30, 2024, Nexus AG's Net Change in Cash amounts to 5.7m EUR.

What is Nexus AG's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
23%

Back to Top